Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Orphazyme
is defunct.
Acquired by kemPharm, May 2022, $7.6M
------------------
If you believe any of this information is incorrect, please
let us know
.